Percutaneous coronary intervention provided better long term results than optimal medical therapy alone in patients with chronic total occlusion: A meta-analysis.


Journal

Indian heart journal
ISSN: 2213-3763
Titre abrégé: Indian Heart J
Pays: India
ID NLM: 0374675

Informations de publication

Date de publication:
Historique:
received: 31 03 2020
revised: 21 06 2020
accepted: 07 07 2020
entrez: 31 8 2020
pubmed: 31 8 2020
medline: 1 4 2021
Statut: ppublish

Résumé

Studies comparing the outcome of percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) versus OMT alone in treatment of chronic total occlusion (CTO) are limited by observational design, variable follow-up period, diverse clinical outcomes, high drop-out and cross-over rates. This study aims to conduct a meta-analysis of published data of observational as well as randomized studies comparing long term outcomes of PCI+OMT versus OMT alone. PubMed, Embase and Cochrane databases were systematically reviewed. 15 studies meeting criteria were included in the meta-analysis. The New-castle Ottawa scale was used to appraise the overall quality of the studies. Random-effects model with inverse variance method was undertaken. Major adverse cardiovascular events (MACE) which comprises of cardiac death, myocardial infarction, stroke, and un-planned revascularization were significantly lower in the PCI+OMT group (RR:0.76; 95% CI:0.61 to 0.95; P=<0.00001; I PCI of CTO is rewarded with better long term outcome, in terms of MACE, all-cause mortality and cardiac death with similar rates of un-planned revascularization.

Identifiants

pubmed: 32861374
pii: S0019-4832(20)30171-1
doi: 10.1016/j.ihj.2020.07.013
pmc: PMC7474112
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-231

Informations de copyright

Copyright © 2020 Cardiological Society of India. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors have none to declare.

Références

J Thorac Dis. 2018 May;10(5):2960-2967
pubmed: 29997962
Braz J Cardiovasc Surg. 2020 Jan 01;34(6):645-652
pubmed: 31194477
Catheter Cardiovasc Interv. 2017 Mar;89(S1):574-581
pubmed: 28318134
J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632
pubmed: 27712774
Eur Heart J. 2018 Jul 7;39(26):2484-2493
pubmed: 29722796
EuroIntervention. 2014 Feb;9(10):1165-72
pubmed: 24561733
Hellenic J Cardiol. 2018 Sep - Oct;59(5):281-287
pubmed: 29605686
Circ J. 2018 Jul 25;82(8):2136-2142
pubmed: 29899202
Heart. 2015 Dec;101(23):1907-14
pubmed: 26552758
J Am Coll Cardiol. 2017 Feb 28;69(8):1095-1096
pubmed: 28231935
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Int J Cardiol. 2015;187:90-6
pubmed: 25828320
Yonsei Med J. 2018 Jul;59(5):602-610
pubmed: 29869458
Circ J. 2016;80(1):211-7
pubmed: 26581754
Scand Cardiovasc J. 1997;31(5):297-303
pubmed: 9406297
JACC Cardiovasc Interv. 2008 Jun;1(3):295-302
pubmed: 19463316
Stat Med. 2008 Feb 28;27(5):746-63
pubmed: 17592831
J Am Coll Cardiol. 2012 Mar 13;59(11):991-7
pubmed: 22402070
J Am Heart Assoc. 2017 Sep 13;6(9):
pubmed: 28903939
Nan Fang Yi Ke Da Xue Xue Bao. 2015 Oct;35(10):1380-3
pubmed: 26547327
Eur Heart J. 2015 Dec 1;36(45):3189-98
pubmed: 26333367
Catheter Cardiovasc Interv. 2013 Jul 1;82(1):76-82
pubmed: 22888007
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Am J Cardiol. 2014 Oct 15;114(8):1158-64
pubmed: 25152423
J Cardiol. 2019 Feb;73(2):156-162
pubmed: 30409701
Catheter Cardiovasc Interv. 2019 May 1;93(6):E320-E325
pubmed: 30549199
JACC Cardiovasc Interv. 2017 Aug 14;10(15):1523-1534
pubmed: 28797429
PLoS One. 2014 Aug 12;9(8):e103850
pubmed: 25117457
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
JACC Cardiovasc Interv. 2015 Feb;8(2):271-279
pubmed: 25700750
Int J Cardiol. 2016 May 1;210:56-62
pubmed: 26930638
Circulation. 2019 Apr 2;139(14):1674-1683
pubmed: 30813758
Int Heart J. 2006 Nov;47(6):811-9
pubmed: 17268116
Stat Med. 2003 Sep 15;22(17):2693-710
pubmed: 12939780
J Am Coll Cardiol. 2014 Jul 22;64(3):235-43
pubmed: 25034057

Auteurs

Dibbendhu Khanra (D)

New Cross Hospital, Royal Wolverhampton NHS Trust, UK. Electronic address: ddk3987@gmail.com.

Vikas Mishra (V)

Department of Cardiology, Super-Speciality Hospital, NSCB Medical College, Jabalpur, MP, India. Electronic address: dr.vikasmishra@gmail.com.

Bhavna Jain (B)

All India Institute of Medical Sciences (AIIMS), Rishikesh, India.

Shishir Soni (S)

Department of Cardiology, All India Institution of Medical Sciences (AIIMS), Rishikesh, India. Electronic address: drshishirsoni07@gmail.com.

Yogesh Bahurupi (Y)

All India Institute of Medical Sciences (AIIMS), Rishikesh, India. Electronic address: yogesh.cfm@aiimsrishikesh.edu.in.

Bhanu Duggal (B)

All India Institute of Medical Sciences (AIIMS), Rishikesh, India. Electronic address: bhanuduggal2@gmail.com.

Sudhir Rathore (S)

Frimley Health NHS Foundation Trust, Camberley, Surrey, UK. Electronic address: sudhirrathore@hotmail.com.

Santanu Guha (S)

Cardiology, Medical College Kolkata, West Bengal, India. Electronic address: guhas55@hotmail.com.

Sharad Agarwal (S)

Sunderland Royal Hospital, Kayll Road, UK. Electronic address: sharad.agarwal@chsft.nhs.uk.

Puneet Aggarwal (P)

Department of Cardiology, ABVIMS and Dr. RML Hospital, New Delhi, India. Electronic address: puneetaggarwal4u@gmail.com.

SantoshKumar Sinha (S)

Department of Cardiology, LPS Institution of Cardiology, Kanpur, Uttar Pradesh, India. Electronic address: fionasan@rediffmail.com.

Kumar Himanshu (K)

Department of Cardiology, LPS Institution of Cardiology, Kanpur, Uttar Pradesh, India. Electronic address: drkumarhimanshu91@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH